Contingency Management for Stimulant Use Disorder: Progress, Challenges, and Recommendations.
| Autor: | Rawson RA; Motivational Incentive Policy Group (Drs Rawson, Erath, Chalk, Clark, Wattenberg, and Roll, and Ms McDaid); Department of Psychiatry, Vermont Center on Behavior and Health, University of Vermont, Burlington, Vermont (Drs Rawson and Erath); Community and Behavioral Health Department, College of Medicine, Washington State University, Pullman, Washington (Drs Roll, McDonell, and Parent); and UCLA Integrated Substance Abuse Programs, Los Angeles, California (Drs Rawson and Freese)., Erath TG, Chalk M, Clark HW, McDaid C, Wattenberg SA, Roll JM, McDonell MG, Parent S, Freese TE |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of ambulatory care management [J Ambul Care Manage] 2023 Apr-Jun 01; Vol. 46 (2), pp. 152-159. Date of Electronic Publication: 2023 Feb 03. |
| DOI: | 10.1097/JAC.0000000000000450 |
| Abstrakt: | The United States is currently in the fourth wave of the overdose crisis wherein stimulants together with fentanyl are the major drivers of overdose deaths. To date, there has been limited effort outside the US Veterans Administration Health System health system to disseminate evidence-based treatment for people with stimulant use disorder. Contingency management, a behavioral intervention in which positive reinforcement is provided for a target behavior indicating treatment progress, has decades of empirical support but limited implementation in real-world, non-US Veterans Administration Health System settings. The purpose of the report is to provide an overview of contingency management, the barriers to adoption, and recommendations for overcoming these barriers. Competing Interests: The authors have no conflicts of interest to disclose. (Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|